NRW.Bank

NRW.BANK is the development bank for the state of North Rhine-Westphalia, established in 2002 and headquartered in Düsseldorf, Germany. The bank focuses on supporting small and medium-sized enterprises, as well as local authorities, by providing a wide range of banking products and services. It specializes in low-interest promotion loans, equity financing, and advisory services, aimed at fostering economic, social, and housing development. NRW.BANK combines various funding programs from the state, federal government, and European Union with its own financial solutions. Its operations encompass key sectors such as economy, housing, and infrastructure, offering comprehensive support for business start-ups, expansions, urban development, and initiatives in environmental protection and innovation. By acting as a neutral partner to banks and savings institutions, NRW.BANK plays a crucial role in enhancing the region's economic landscape.

Matthias Bolowski

Investment Manager

102 past transactions

Pilzling

Seed Round in 2025
Pilzling is an urban mushroom farm that specializes in producing gourmet mushrooms by utilizing local waste materials, such as coffee grounds and wood shavings. This innovative approach not only creates nutrient-rich substrates for mushroom cultivation but also contributes to waste reduction and promotes sustainability. The team at Pilzling comprises experts in mycology, biology, and engineering, who work collaboratively to enhance farming methods. By embracing the principles of the circular economy, Pilzling aims to provide consumers with high-quality mushroom products and meat substitutes, while fostering a sustainable regional network.

ScrapBees

Seed Round in 2025
ScrapBees is a pick-up service for recycling scrap metal from public and private residences and businesses. When it comes to converting what was formerly deemed waste into raw material, they are a trustworthy partner for artisans, private homes, and entrepreneurs. the first scrapyard on wheels in the world, quick, technologically advanced, and practical.

Alteva

Pre Seed Round in 2025
Alteva develops battery cells for the decarbonisation of the global transport sector, and focus on high-energy density battery cells with high safety profiles specifically designed for the aviation and heavy-duty transport sectors.

GEMESYS

Pre Seed Round in 2024
Founded as a spin-off from Ruhr-University Bochum in Germany, GEMESYS is pioneering next-generation AI chips with cutting-edge technology built on memristors—novel electronic components that enable highly efficient neural network processing. Designed for on-device training and inference, GEMESYS' technology unlocks a range of new use cases for Edge AI.

Valuedesk

Series A in 2024
Valuedesk GmbH is a service company based in Bielefeld, Germany, that specializes in structured savings and efficiency management. Founded in 2017, Valuedesk provides a comprehensive solution that enables organizations to record, analyze, and implement improvements and savings across various industries, including automotive, biotechnology, energy, food, furniture, construction, chemicals, IT, logistics, telecommunications, electronics, pharmaceuticals, and textiles. The company's adaptable system focuses on cost optimization, utilizing methodologies, workshops, and seminars to enhance transparency and communication within teams. By applying systematic approaches and technology, Valuedesk helps clients identify hidden savings and optimization potentials, develop tailored implementation concepts, and achieve long-term profitability.

Sphingotec GmbH

Series C in 2024
Sphingotec GmbH is a biomarker company based in Brandenburg, Germany, founded in 2002. The company specializes in developing and marketing in vitro diagnostic solutions that utilize novel blood-based protein biomarkers for the diagnosis, prediction, and monitoring of acute medical conditions, including acute heart failure, acute kidney injury, and circulatory shock. Sphingotec also produces microtiter plates, which are commonly used in analytical research and diagnostic testing laboratories. Its focus is on addressing critically underserved diagnostic needs in the field of acute care, with an emphasis on improving patient outcomes through innovative biomarker technologies.

ECO2GROW

Seed Round in 2024
ECO2GROW is dedicated to assisting industrial small and medium-sized enterprises (SMEs) in navigating the complexities of the renewable energy landscape. The company provides these businesses with direct access to green electricity sourced from solar and wind farms, enabling them to secure long-term, fixed wholesale energy contracts. By integrating energy procurement with energy management, ECO2GROW equips its clients with the tools necessary to reduce pollution and meet their sustainability objectives. This approach helps SMEs achieve their climate goals while benefiting from reliable and affordable renewable energy solutions.

Black Semiconductor

Series A in 2024
Black Semiconductor is a pioneer in connectivity, specializing in the development of semiconductor microchips that integrate graphene photonics and electronics on a single wafer. This unique technology enables high-speed, low-latency chip-to-chip communication by converting electrical signals to light, significantly enhancing data transfer rates while reducing energy consumption. By utilizing optical waveguides instead of traditional copper connections, Black Semiconductor facilitates longer-distance and more efficient data movement, addressing the bandwidth limitations faced by current computing architectures. The company's photonic circuits are designed to be compatible with existing silicon technology, allowing seamless integration into various industries. With its advanced manufacturing capabilities, including a scalable pilot line for 300mm wafer technology in Aachen, Germany, Black Semiconductor is positioned to deliver a new generation of energy-efficient and high-performance microchips that transform connectivity in computing.

Prothea Technologies

Series A in 2024
Prothea Technologies is a private medical technology business to provide lung cancer biopsy and therapy in a single hospital visit.

CryoTherapeutics

Series B in 2024
CryoTherapeutics GmbH, founded in 2009 and based in Cologne, Germany, specializes in developing a proprietary cryotherapy system aimed at treating coronary artery disease, which is a leading cause of heart attacks. The company focuses on demonstrating clinical benefits and advancing early-stage commercialization of its innovative catheter system that employs cryoenergy to address issues related to diseased coronary arteries. By proving the safety and efficacy of cryoenergy in the cardiovascular context, CryoTherapeutics aims to provide heart surgeons with an effective tool to prevent heart attacks and enhance patient outcomes.

widu

Pre Seed Round in 2024
widu enables real estate and accommodation companies to source visuals (photography, video, drone) at scale through its serviced marketplace

Companyon Analytics

Pre Seed Round in 2023
Developer of a planning and controlling software designed to offer easy-to-understand visual presentation. The company's software helps in managing director cockpit, digital BWA, balance sheet, reports, visualizations in graphs, liquidity calculation and forecast, planning and scenario analysis, enabling small and medium-sized companies to set up a system for planning, controlling, and liquidity management in minutes to have clarity about their company's financial situation.

consalio

Seed Round in 2023
consalio helps management stay in control of the advisor's spending before the bill arrives and increases the impact of external partnerships. It is an advisory spend management solution company. An online inquiry form is available on their website.

bNear

Pre Seed Round in 2023
bNear is a virtual office platform designed to enhance communication and collaboration for hybrid and remote teams through integration with Microsoft Teams. The platform offers a social space that facilitates faster collaboration and communication among team members, helping to optimize alignment and improve efficiency. By fostering an environment that encourages creativity, team spirit, and motivation, bNear aims to increase employee engagement and enhance the overall work experience.

Elixion Medical

Seed Round in 2023
Elixion helps to attenuate care shortage in hospitals and care units by automated catheter and drain monitoring with medical IoT devices and AI backed analytics.

talpasolutions

Series B in 2023
talpasolutions a predictive SaaS analytics provider for the mining industry that helps companies optimize machine performance, reduce breakdowns, and improve safety by making data more understandable. talpasolutions makes it possible for operators and machine manufacturers in heavy industry to use machine data that would have otherwise been lost. talpasolutions concentrates on building visualization and analysis applications for the industrial internet. In the first step, large amounts of data from the machines are recorded. Comprehendable visualizations allow for different stakeholders to understand relationships based on sensor data and contextual data and to react to critical information, which would otherwise have been buried in the data transfer. In the second step the newest predictive models are applied to eliminate events such as errors and the breakdown of machines critical to the process. This increases not only the availability but also the workload of the machines. talpasolutions has built a network out of industry partners to develop solutions that stretch across various sectors and unify industry experience, data science, and workflow connectivity. Using predictive instructions our platform recognizes problems before they occur and supports users with workflow-based processes. Our applications make it possible to collect performance data from machines in order to recommend optimal fleet combinations for respective scenarios to customers. This leads to more operating hours, higher efficiency, and an improved lifetime value of the machines.

Machine2Human Solutions

Convertible Note in 2023
AI solution for the CRM environment to support decision making and problem solving through speech analysis in a customer interaction, as well as automation of documentation processes and knowledge base creation.

Refined Laser Systems

Seed Round in 2023
Refined Laser Systems is a dynamic biophotonics company.It specialises in creating innovative laser systems for SRS-microscopy and quantum technology.

VMRay

Series B in 2022
The VMRay Platform is a breakthrough solution for dynamic analysis of advanced threats, including zero day and targeted attacks. By surmounting inherent flaws that plague other products, VMRay Analyzer has become the gold standard for malware sandboxing among leading DFIR teams worldwide. The core of the VMRay Platform is an agentless, hypervisor-based sandbox, which is unique in combining near-total evasion resistance with full visibility into malware behavior: a trait we call X-Ray Vision. Because nothing touches or modifies the analysis environment, monitoring is invisible, and even the most evasive malware strains fully execute in the sandbox. By monitoring every interaction between malware and the target system, VMRay captures a complete and accurate record of threat behavior – data that enriches detection, incident response, digital forensics, and threat intelligence. VMRay Intelligent Monitoring excels over other solutions in distinguishing between malicious behavior and legitimate activity. As a result, VMRay Analyzer delivers precise, noise-free output that reduces false positive rates to near zero. This shortens investigations, enhances efficiency and prevents legitimate traffic from being blocked

Certif-ID International GmbH

Seed Round in 2022
Certif-ID International GmbH operates an online platform that facilitates the issuance of blockchain-based digital certificates and badges. The company aims to create a skills ecosystem that connects educators, industries, and candidates, enabling effective sourcing, management, and development of talent aligned with industry standards. By leveraging the European ESCO framework, Certif-ID harmonizes job profiles and matches skills to job requirements. Its intelligent matching engine uses data to link candidates with suitable job opportunities, while the SkillPass feature allows candidates to showcase their qualifications, including video interviews and project work. The platform supports companies in managing internal talent development and addressing skills shortages, particularly in developing markets. Through its interconnected network of training and industry partners, Certif-ID enhances transparency in credential verification and streamlines cross-border recruitment efforts.

Resolve BioSciences

Series B in 2022
Resolve BioSciences GmbH, founded in 2016 and based in Monheim am Rhein, Germany, specializes in spatial multiomics analysis platforms that enhance the understanding of single-cell spatial biology. The company's technology offers a comprehensive, high-resolution view of subcellular gene expression activities, which is crucial for advancements in various fields such as oncology, neuroscience, and infectious diseases. Resolve BioSciences provides a range of services and expertise in bioinformatics, imaging, genomics, transcriptomics, histology, and pathology, among other areas. This innovative approach supports researchers in their efforts to explore complex biological systems and improve outcomes in health and agriculture.

catchHR

Seed Round in 2022
catchHR is a technology company specializing in recruitment software that employs artificial intelligence to streamline the hiring process for businesses. The platform facilitates applicant search, selection, and management, allowing companies to efficiently identify suitable candidates. Its mobile application connects to 600 online channels, enhancing the reach and visibility of job advertisements. With features such as intuitive application forms, automated candidate sourcing, and personality matching, catchHR enables organizations to analyze applicants' skills and traits effectively. By automating various aspects of recruitment, the company helps businesses optimize their hiring efforts and improve overall efficiency in finding the right employees.

consalio

Seed Round in 2022
consalio helps management stay in control of the advisor's spending before the bill arrives and increases the impact of external partnerships. It is an advisory spend management solution company. An online inquiry form is available on their website.

Drop Friends

Pre Seed Round in 2022
Drop Friends is an app that accepts packages for your community and ties them to an office or hotel at the time of delivery. It is a platform for parcel shipments.

icho

Seed Round in 2022
icho systems gmbh, based in Duisburg, Germany, specializes in developing interactive therapy solutions for individuals with neurological conditions, particularly dementia, stroke, and Parkinson's disease. The company's flagship product, the ichó therapy ball, employs advanced sensor technology to respond to user interactions—such as rolling, catching, or shaking—with colored lights, sounds, and vibrations. This innovative device is designed to enhance cognitive and motor skills through engaging therapeutic activities, offering over 150 guideline-compliant therapy applications developed in collaboration with healthcare professionals. Since its introduction in 2020, the ichó therapy ball has been implemented in more than 850 facilities, and in 2023, it received funding as a preventive service under care insurance provisions. ichó aims to facilitate outpatient care for patients, ensuring effective therapeutic support in home settings. The product can be purchased directly from the company's website.

Fimo Health

Seed Round in 2022
Fimo Health is building the leading ecosystem for patients suffering from fatigue in chronic diseases by combining data, science and technology. Our solution is already available for Long Covid, Multiple Sclerosis and ME/CFS (only CE-certified solution for Long Covid) and soon will follow a version for Oncology. The app is already reimbursed by several health insurances with more than 20 million members.

Einhundert

Venture Round in 2022
Einhundert Energy, founded in 2017 and headquartered in Cologne, Germany, specializes in providing green and digital energy solutions for tenants and property managers. The company offers a comprehensive service package that includes the planning, installation, operation, and maintenance of photovoltaic systems, allowing tenants to access low-cost solar energy. Einhundert Energy also features a digital billing platform that provides transparent monthly billing based on actual power consumption, enabling users to monitor and manage their energy usage through a dedicated app. This system allows for seamless integration with various technologies, including heat and water billing, smoke detectors, heat pumps, and e-charging stations, contributing to consistent cost transparency and efficient energy management.

Ducktrain

Seed Round in 2021
Multiple vehicles (we call them ducks) can form a train for efficient transportation on longer distances within cities and industry areas. Ducktrain provides vehicle platforms and automation technology that will change urban and industrial logistics.

Emergence Therapeutics

Series A in 2021
Emergence Therapeutics AG is a biopharmaceutical company based in Duisburg, Germany, focused on developing novel antibody-drug conjugate (ADC) immuno-therapeutics for high-need cancers. Founded in 2019, the company is advancing its lead program, which combines a highly specific antibody with optimized linker and payload technology to target Nectin-4, a clinically validated target for various cancers. This approach is inspired by the success of enfortumab vedotin, an approved treatment for urothelial cancers. Emergence Therapeutics is also exploring opportunities to create additional first- or best-in-class ADCs, aiming to address significant therapeutic needs in oncology.

Operaize

Seed Round in 2021
Operaize offers Cognitive Operations, a cloud platform for AI-based production planning that integrates into an existing planning landscape via APIs or special SAP integration and solves existing planning challenges. Cognitive Operations collects planning and master data from existing ERP and planning systems, converts it into a data structure suitable for the various AI-based planning and optimization processes, and generates an optimal production plan in seconds based on a set of framework conditions, constraints, and objectives.

Coachinho

Seed Round in 2021
Coachinho is a platform dedicated to football coaching and player development, catering to aspiring players, professional coaches, and football enthusiasts. It offers a comprehensive library of coaching drills, tactical strategies, and training sessions created by football experts, covering all levels from beginner to advanced. The platform enhances the coaching experience through interactive skill games and employs advanced AI technology to analyze performance, providing real-time feedback and personalized training recommendations. By focusing on sustainable performance improvement, Coachinho empowers footballers and coaches with the knowledge and tools necessary for optimal game development.

Abalos Therapeutics

Series A in 2021
The company intends to use the funds to advance its arenavirus-based lead candidates towards clinical testing. They will develop the initial product candidates using its proprietary Fast Evolution platform, which will generate virus strains with optimized anti-tumoral properties. These candidates will be selected based on their ability to re-program the immune system to specifically and efficiently eliminate the malignant tumor tissue.

Lumoview Building Analytics

Convertible Note in 2021
Lumoview Building Analytics GmbH, founded in 2019 and based in Cologne, Germany, specializes in developing an indoor measurement system for automated building analysis. The company's technology allows for rapid digitization of buildings, completing the process in just two seconds per room. Using a user-friendly device, Lumoview collects data that is then analyzed in the cloud through a highly automated platform. This connected online system enables building owners to make informed decisions to enhance their properties and reduce CO2 emissions, ultimately contributing to more efficient and sustainable building management.

CEVEC Pharmaceuticals

Venture Round in 2021
CEVEC Pharmaceuticals GmbH specializes in the manufacture of biopharmaceutical molecules featuring human glycosylation patterns. The company develops the CAP-GO platform, which includes optimized expression vectors and a cell line generation process that is free from serum and animal components. This platform enables the efficient production of complex, glycosylated proteins and therapeutic proteins, including monoclonal antibodies. CEVEC also offers the CAP-GT platform for the industrial-scale production of gene therapy vectors, such as Lentiviral, Adenoviral, and AAV types. Additionally, the company provides contract manufacturing services. Founded in 2001 and based in Cologne, Germany, CEVEC has established a strategic collaboration with BioLamina AB to enhance its capabilities in biopharmaceutical production.

Masterplan.com

Debt Financing in 2021
Masterplan.com is a developer of a SaaS platform focused on corporate education. The platform provides practical lessons across diverse topics, short learning sessions, and e-learning videos, all designed to facilitate a hands-on review of knowledge. This approach enables users to seamlessly incorporate digital learning into their work routines, enhancing their skills and productivity.

aifora

Seed Round in 2021
aifora GmbH is a software company based in Düsseldorf, Germany, founded in 2017. It specializes in developing a platform that predicts consumer behavior and offers automation solutions for retail companies. The company's software utilizes big data and machine learning to provide services such as price optimization and inventory management, helping retailers make informed decisions about order quantities and merchandise distribution. By leveraging deep learning algorithms, aifora enables businesses to create customer-centric merchandising strategies, optimize pricing, and manage promotional activities effectively. The platform aims to improve profitability and enhance customer experiences while fostering a shared data ecosystem among brands and retailers. Through intelligent automation, aifora reduces the burden of repetitive tasks, allowing merchandisers to concentrate on product innovation and enhancing consumer engagement.

Semalytix

Series A in 2021
Semalytix GmbH, founded in 2015 and headquartered in Bielefeld, Germany, specializes in developing an artificial intelligence-driven platform designed to extract and summarize trends in the perception of high-cost therapies, particularly in oncology, immunology, and metabolism. The company's flagship tool, Pharos, serves as a real-world evidence generation solution that ingests data from various sources such as CRM systems, social media, job advertisements, and clinical studies. By processing information from patient forums and online discussions, Semalytix organizes this data to provide the pharmaceutical industry with valuable insights. This enables the medical community to make informed decisions that can improve treatment outcomes and enhance the understanding of patient experiences with medications.
The age of decarbonization has finally begun, however, as emphasized by the latest IPCC report, we are still moving extremely slowly towards a net-zero future. The problem is that companies now stand under immense pressure to accelerate their decarbonization efforts: - The best talent wants to work for companies that will positively shape our future. - Shareholders are demanding companies execute on climate-friendly strategy - Financing conditions are increasingly made dependent on companies ESG ratings - A high price on carbon emissions seems inevitable - and most importantly we are running out of time! At eevie we, therefore, want to accelerate climate action by helping our leading enterprise corporations create and foster a climate-friendly work culture. Only if our leading corporations embrace a climate-friendly work culture and strong signals to their employees that climate is an essential part of their work, only then will they be able to attract the best talent and transform their business from within in order to reach their net-zero emissions goals quickly.

Lupiter

Pre Seed Round in 2021
It's better to have a conversation. We help brands to pioneer Conversational Commerce by using WhatsApp. Send out WhatsApp newsletters to your audience. Sell your product or service customers in chat. Engage with your customers directly where their friends are. A conversational commerce suite for consumer brands, who want to talk and build relationships with their customers. We guide brands from setup to sales ready and enable your next marketing and sales channel. 100% personalized.

Coachinho

Seed Round in 2021
Coachinho is a platform dedicated to football coaching and player development, catering to aspiring players, professional coaches, and football enthusiasts. It offers a comprehensive library of coaching drills, tactical strategies, and training sessions created by football experts, covering all levels from beginner to advanced. The platform enhances the coaching experience through interactive skill games and employs advanced AI technology to analyze performance, providing real-time feedback and personalized training recommendations. By focusing on sustainable performance improvement, Coachinho empowers footballers and coaches with the knowledge and tools necessary for optimal game development.

talpasolutions

Series A in 2020
talpasolutions a predictive SaaS analytics provider for the mining industry that helps companies optimize machine performance, reduce breakdowns, and improve safety by making data more understandable. talpasolutions makes it possible for operators and machine manufacturers in heavy industry to use machine data that would have otherwise been lost. talpasolutions concentrates on building visualization and analysis applications for the industrial internet. In the first step, large amounts of data from the machines are recorded. Comprehendable visualizations allow for different stakeholders to understand relationships based on sensor data and contextual data and to react to critical information, which would otherwise have been buried in the data transfer. In the second step the newest predictive models are applied to eliminate events such as errors and the breakdown of machines critical to the process. This increases not only the availability but also the workload of the machines. talpasolutions has built a network out of industry partners to develop solutions that stretch across various sectors and unify industry experience, data science, and workflow connectivity. Using predictive instructions our platform recognizes problems before they occur and supports users with workflow-based processes. Our applications make it possible to collect performance data from machines in order to recommend optimal fleet combinations for respective scenarios to customers. This leads to more operating hours, higher efficiency, and an improved lifetime value of the machines.

Lupiter

Pre Seed Round in 2020
It's better to have a conversation. We help brands to pioneer Conversational Commerce by using WhatsApp. Send out WhatsApp newsletters to your audience. Sell your product or service customers in chat. Engage with your customers directly where their friends are. A conversational commerce suite for consumer brands, who want to talk and build relationships with their customers. We guide brands from setup to sales ready and enable your next marketing and sales channel. 100% personalized.

Social Impact Network

Convertible Note in 2020
Social Impact Network is a fully decentralized ecosystem for impact investing. Social Impact Network empowers impact investors to earn high returns while effortlessly making a positive social impact.

Lumoview Building Analytics

Convertible Note in 2020
Lumoview Building Analytics GmbH, founded in 2019 and based in Cologne, Germany, specializes in developing an indoor measurement system for automated building analysis. The company's technology allows for rapid digitization of buildings, completing the process in just two seconds per room. Using a user-friendly device, Lumoview collects data that is then analyzed in the cloud through a highly automated platform. This connected online system enables building owners to make informed decisions to enhance their properties and reduce CO2 emissions, ultimately contributing to more efficient and sustainable building management.

limbiq.com

Seed Round in 2020
limbiq.com offers a browser-based Software-as-a-Service solution for Supply Chain Management to B2B customers from industry, trade and logistics alike.

icho

Funding Round in 2020
icho systems gmbh, based in Duisburg, Germany, specializes in developing interactive therapy solutions for individuals with neurological conditions, particularly dementia, stroke, and Parkinson's disease. The company's flagship product, the ichó therapy ball, employs advanced sensor technology to respond to user interactions—such as rolling, catching, or shaking—with colored lights, sounds, and vibrations. This innovative device is designed to enhance cognitive and motor skills through engaging therapeutic activities, offering over 150 guideline-compliant therapy applications developed in collaboration with healthcare professionals. Since its introduction in 2020, the ichó therapy ball has been implemented in more than 850 facilities, and in 2023, it received funding as a preventive service under care insurance provisions. ichó aims to facilitate outpatient care for patients, ensuring effective therapeutic support in home settings. The product can be purchased directly from the company's website.

COMPEON

Series C in 2020
COMPEON is a leading financing portal in Germany that specializes in providing small and medium-sized enterprises (SMEs) with tailored financial solutions. By submitting a query on their website, companies can receive customized offers from over 220 banks, leasing companies, and other financial providers at no cost. Annually, COMPEON processes financing inquiries totaling €2.5 billion, offering a diverse range of products including loans, leasing agreements, factoring, mezzanine capital, and project financing. Established in 2013, the company is managed by its founders—Kai Böringschulte, Dr. Nico Peters, and Dr. Frank Wüller—and is backed by investors such as DvH Ventures, b-to-v, and Tengelmann Ventures. Through its online platform, COMPEON enables SMEs to efficiently compare and secure the financial products they need to support their growth and projects.

Ubirch

Seed Round in 2020
Ubirch GmbH, founded in 2014 and based in Cologne, Germany, specializes in developing Internet of Things (IoT) software security solutions utilizing blockchain technology. The company offers a platform that enables the secure transmission and sharing of carbon footprint data, allowing businesses to subscribe and calculate their share of emissions. Ubirch's systems cryptographically sign carbon disclosures, facilitating their reuse within a network and enhancing transparency. This approach addresses the growing importance of climate reduction measures for companies aiming to meet environmental, social, and governance (ESG) criteria. Ubirch serves various industries, including production, insurance, energy, and logistics, helping organizations compile their Scope 3 carbon footprints in an auditable manner.

Lumoview Building Analytics

Funding Round in 2020
Lumoview Building Analytics GmbH, founded in 2019 and based in Cologne, Germany, specializes in developing an indoor measurement system for automated building analysis. The company's technology allows for rapid digitization of buildings, completing the process in just two seconds per room. Using a user-friendly device, Lumoview collects data that is then analyzed in the cloud through a highly automated platform. This connected online system enables building owners to make informed decisions to enhance their properties and reduce CO2 emissions, ultimately contributing to more efficient and sustainable building management.

CHRONEXT

Series E in 2020
CHRONEXT is a comprehensive platform dedicated to the trading of luxury watches. It facilitates the buying, selling, and servicing of watches through its in-house certified watchmaking atelier. The company provides a wide range of options, including brand new, pre-owned, and vintage timepieces, all of which undergo thorough inspection to ensure quality and authenticity. Through its digital platform, CHRONEXT aims to streamline the luxury watch market for both buyers and sellers.

Abalos Therapeutics

Series A in 2019
The company intends to use the funds to advance its arenavirus-based lead candidates towards clinical testing. They will develop the initial product candidates using its proprietary Fast Evolution platform, which will generate virus strains with optimized anti-tumoral properties. These candidates will be selected based on their ability to re-program the immune system to specifically and efficiently eliminate the malignant tumor tissue.

Frontastic

Seed Round in 2019
Frontastic is a developer of a front-end development platform that aims to enhance the digital customer experience. Its Frontend-as-a-Service solution is designed for online retailers, brands, marketplaces, and agile start-ups, emphasizing a "mobile first" approach. This platform enables users to easily implement customer-centric designs with minimal IT resources, allowing for seamless integration of APIs into websites. By providing a user-friendly interface, Frontastic facilitates the creation of customized online presences, positioning itself as a leading front-end solution in the evolving API economy.

Social Impact Network

Convertible Note in 2019
Social Impact Network is a fully decentralized ecosystem for impact investing. Social Impact Network empowers impact investors to earn high returns while effortlessly making a positive social impact.

HoloBuilder

Corporate Round in 2019
HoloBuilder Inc. is a software company that specializes in construction progress management through an artificial intelligence-based platform. Founded in 2015 and headquartered in San Francisco, California, HoloBuilder offers a web-based solution that enables construction teams to capture, communicate, and manage project progress using 360-degree photos. The platform integrates with Autodesk BIM 360 and allows users to document construction site progress at every stage. With its subscription-based model, HoloBuilder provides virtual reality capabilities and organizes photos by location and time, allowing engineers, contractors, and clients to virtually visit construction sites at any time. The platform has gained trust from over 28,000 construction projects across 35 countries, helping teams improve efficiency, adhere to schedules, and manage budgets effectively.

Taxy.io

Seed Round in 2019
Taxy.io GmbH, founded in 2018 and based in Aachen, Germany, specializes in automating tax consulting and research through its AI-driven platform, Taxy.io. This platform serves as a central information hub for digital tax intelligence, utilizing machine learning and natural language processing to facilitate semantic and context-specific searches. Taxy.io aims to enhance the efficiency of tax professionals, including lawyers, tax consultants, auditors, and corporate finance employees, by enabling them to quickly access specific information and conduct automated legal analysis. The company's focus is on improving productivity and minimizing compliance risks for accounting firms and tax departments within small to medium-sized enterprises and larger organizations.

Einhundert

Venture Round in 2018
Einhundert Energy, founded in 2017 and headquartered in Cologne, Germany, specializes in providing green and digital energy solutions for tenants and property managers. The company offers a comprehensive service package that includes the planning, installation, operation, and maintenance of photovoltaic systems, allowing tenants to access low-cost solar energy. Einhundert Energy also features a digital billing platform that provides transparent monthly billing based on actual power consumption, enabling users to monitor and manage their energy usage through a dedicated app. This system allows for seamless integration with various technologies, including heat and water billing, smoke detectors, heat pumps, and e-charging stations, contributing to consistent cost transparency and efficient energy management.

Unu motors

Series B in 2018
Unu GmbH, founded in 2013 and headquartered in Berlin, Germany, specializes in the design, development, and sale of electric scooters. The company aims to enhance urban mobility by providing stylish, emission-free, and quiet scooters that feature portable batteries, allowing users to charge them conveniently at home. Unu's first electric scooter was launched in 2014, marking the beginning of its commitment to connecting people with their cities. In addition to selling scooters through retail outlets and online, the company offers various financing options and after-sales support services to enhance customer experience.

icho

Seed Round in 2018
icho systems gmbh, based in Duisburg, Germany, specializes in developing interactive therapy solutions for individuals with neurological conditions, particularly dementia, stroke, and Parkinson's disease. The company's flagship product, the ichó therapy ball, employs advanced sensor technology to respond to user interactions—such as rolling, catching, or shaking—with colored lights, sounds, and vibrations. This innovative device is designed to enhance cognitive and motor skills through engaging therapeutic activities, offering over 150 guideline-compliant therapy applications developed in collaboration with healthcare professionals. Since its introduction in 2020, the ichó therapy ball has been implemented in more than 850 facilities, and in 2023, it received funding as a preventive service under care insurance provisions. ichó aims to facilitate outpatient care for patients, ensuring effective therapeutic support in home settings. The product can be purchased directly from the company's website.

Jamata Events

Seed Round in 2018
The platform aggregates event data from all major ticket providers in the world.

Holocafé

Seed Round in 2018
Holocafé ist a franchiser company developing exclusive, shared-space VR experiences for location-based entertainment. Content aside, we have developed an entire one-stop platform solution to provide leisure operators with all tools they need: From ticketing and online payment over staff scheduling and accounting to store automization and content distribution. We are presently running three pilot stores in Germany with a fourth one scheduled to open this spring, in addition to a number of international licensees.

Banking One

Pre Seed Round in 2018
Banking One is a developer of a customer relationship platform designed to enhance the understanding of retail bank customers through data-driven insights. The platform enables sales managers to identify customers who are currently interested in financial products, allowing for more targeted engagement. By filtering out the most promising prospects, Banking One helps banks allocate their sales resources more effectively, leading to increased earnings and improved customer satisfaction. Customers are contacted based on their needs rather than being inundated with irrelevant offers, ensuring a more personalized banking experience.

Hemovent

Series A in 2017
​​​Based in Aachen, Germany, Hemovent is a privately held medical technology company that is developing a portable ECMO (Extra Corporeal Membrane Oxygenation) unit. Hemovent was founded by serial entrepreneur, Christof Lenz and Oliver Marseille, inventors of the company’s proprietary platform. It is the goal of the company to develop an innovative solution, with precision and craftsmanship, that will aide patients with lung and heart function while allowing them to be mobile.

Unu motors

Series A in 2017
Unu GmbH, founded in 2013 and headquartered in Berlin, Germany, specializes in the design, development, and sale of electric scooters. The company aims to enhance urban mobility by providing stylish, emission-free, and quiet scooters that feature portable batteries, allowing users to charge them conveniently at home. Unu's first electric scooter was launched in 2014, marking the beginning of its commitment to connecting people with their cities. In addition to selling scooters through retail outlets and online, the company offers various financing options and after-sales support services to enhance customer experience.

ShopCo Technologies

Seed Round in 2017
Shop uses Artificial Intelligence to empower online shopping experience for customers. It is a universal shopping cart browser extension that keeps all the items of its users across the web in one spot. Stores can be registered online and without any hassle. It helps its users browse through a wide range of online stores and checkout from one spot. The company gives ability to connect to all its users existing retailer accounts. It also secures data with encryption methods and two-step verifications. Shop is a U.S.-based company that was founded in 2014 by Jay Habib.

CardioSecur

Series B in 2017
CardioSecur, a subsidiary of Personal MedSystems, focuses on innovative mobile health solutions, particularly in the realm of instant cardiac monitoring. The company has developed a smartphone-based ECG application that includes a specialized set of electrodes for efficient data collection. This application allows users to conduct personalized cardiac monitoring and facilitates the sharing of results with healthcare providers, enabling patients to receive timely recommendations on their health status in under a minute. By prioritizing ease of use and sophisticated design, CardioSecur aims to deliver professional-grade ECG technology for individuals, enhancing personal health management.

Mapudo

Venture Round in 2016
Mapudo is a supplier-independent marketplace for for metals. Mapudo is bringing the metals supply industry online. They are the first company offering an independent online distribution channel for metals distributors and simplifying significantly metals procurement for buyers.

Rigontec

Series A in 2016
Rigontec is the leader in RIG-I targeting RNA therapeutics developing novel immuno-oncology treatment options.

CryoTherapeutics

Series B in 2016
CryoTherapeutics GmbH, founded in 2009 and based in Cologne, Germany, specializes in developing a proprietary cryotherapy system aimed at treating coronary artery disease, which is a leading cause of heart attacks. The company focuses on demonstrating clinical benefits and advancing early-stage commercialization of its innovative catheter system that employs cryoenergy to address issues related to diseased coronary arteries. By proving the safety and efficacy of cryoenergy in the cardiovascular context, CryoTherapeutics aims to provide heart surgeons with an effective tool to prevent heart attacks and enhance patient outcomes.

CHRONEXT

Series C in 2016
CHRONEXT is a comprehensive platform dedicated to the trading of luxury watches. It facilitates the buying, selling, and servicing of watches through its in-house certified watchmaking atelier. The company provides a wide range of options, including brand new, pre-owned, and vintage timepieces, all of which undergo thorough inspection to ensure quality and authenticity. Through its digital platform, CHRONEXT aims to streamline the luxury watch market for both buyers and sellers.

Hemovent

Series A in 2016
​​​Based in Aachen, Germany, Hemovent is a privately held medical technology company that is developing a portable ECMO (Extra Corporeal Membrane Oxygenation) unit. Hemovent was founded by serial entrepreneur, Christof Lenz and Oliver Marseille, inventors of the company’s proprietary platform. It is the goal of the company to develop an innovative solution, with precision and craftsmanship, that will aide patients with lung and heart function while allowing them to be mobile.

Bomedus

Series B in 2015
Bomedus is a Germany-based medical device company established in 2011, focused on improving mobility for individuals suffering from chronic pain, particularly back pain. The company's innovative devices employ an electro-therapeutic method aimed at providing permanent and sustainable pain reduction. By non-invasively modulating pathologically altered neuronal impulses, Bomedus seeks to enhance the quality of life for patients experiencing chronic discomfort.

CHRONEXT

Series B in 2015
CHRONEXT is a comprehensive platform dedicated to the trading of luxury watches. It facilitates the buying, selling, and servicing of watches through its in-house certified watchmaking atelier. The company provides a wide range of options, including brand new, pre-owned, and vintage timepieces, all of which undergo thorough inspection to ensure quality and authenticity. Through its digital platform, CHRONEXT aims to streamline the luxury watch market for both buyers and sellers.

CEVEC Pharmaceuticals

Venture Round in 2015
CEVEC Pharmaceuticals GmbH specializes in the manufacture of biopharmaceutical molecules featuring human glycosylation patterns. The company develops the CAP-GO platform, which includes optimized expression vectors and a cell line generation process that is free from serum and animal components. This platform enables the efficient production of complex, glycosylated proteins and therapeutic proteins, including monoclonal antibodies. CEVEC also offers the CAP-GT platform for the industrial-scale production of gene therapy vectors, such as Lentiviral, Adenoviral, and AAV types. Additionally, the company provides contract manufacturing services. Founded in 2001 and based in Cologne, Germany, CEVEC has established a strategic collaboration with BioLamina AB to enhance its capabilities in biopharmaceutical production.

PRECIRE

Venture Round in 2015
PRECIRE Technologies is the innovative leader of speech analysis technology. Since 2012, the company has been developing the PRECIRE® technology, which decodes written speech and provides fascinating insights into the interaction of personality, speech, and behavior. The algorithm uses text to create a valid picture of employees, customers, applicants and other conversational partners. PRECIRE® opens up new paths to intelligent, individualized and efficient interaction. PRECIRE® transforms texts into hundreds of thousands of tiny features and compares them to patterns and structures of thousands of psychologically substantiated reference data sets. Thus, the software can make precise statements about the communicative effect of speech as well as about emotions, personality and linguistic competence of a person or a group of persons.

Rigontec

Series A in 2015
Rigontec is the leader in RIG-I targeting RNA therapeutics developing novel immuno-oncology treatment options.

Mapudo

Seed Round in 2015
Mapudo is a supplier-independent marketplace for for metals. Mapudo is bringing the metals supply industry online. They are the first company offering an independent online distribution channel for metals distributors and simplifying significantly metals procurement for buyers.

Protagen

Venture Round in 2014
Protagen is a precision medicine specialist that support drug development, facilitate treatment strategies and improve patient management. Protagen is at the forefront of immuno-profiling and the discovery of novel autoantibody signatures for autoimmune disease and immuno-oncology. Protagen’s SeroTag® technology identifies biomarkers that address a number of challenges currently hindering the successful development and broader application of both cancer immunotherapies and novel treatments for autoimmune diseases. The company is a leader in patient stratification for autoimmune disease, having developed disease-specific NavigAID stratification panels that profile individual patient’s autoimmune condition and immune status. This precision medicine approach allows for the development and implementation of more targeted therapies for diseases such as systemic lupus erythematosus (SLE), systemic sclerosis (SSc), rheumatoid arthritis (RA), Sjögren’s syndrome (SjS) and others.

Vimecon

Venture Round in 2014
Vimecon GmbH, founded in 2005 and headquartered in Herzogenrath, Germany, specializes in the development and production of laser catheters specifically designed for the treatment of heart diseases, with a primary focus on atrial fibrillation. The company also manufactures a range of products for the medical technology and biotechnology sectors, including microscopically small catheters and micro materials handling techniques that facilitate precise measurement and dosage. Additionally, Vimecon provides advisory services to various clients in both academic and industrial research and development. Its innovations aim to enhance healthcare outcomes and support advancements in the treatment of cardiovascular diseases and cardiac arrhythmias.

CHRONEXT

Series A in 2014
CHRONEXT is a comprehensive platform dedicated to the trading of luxury watches. It facilitates the buying, selling, and servicing of watches through its in-house certified watchmaking atelier. The company provides a wide range of options, including brand new, pre-owned, and vintage timepieces, all of which undergo thorough inspection to ensure quality and authenticity. Through its digital platform, CHRONEXT aims to streamline the luxury watch market for both buyers and sellers.

Rigontec

Series A in 2014
Rigontec is the leader in RIG-I targeting RNA therapeutics developing novel immuno-oncology treatment options.

AYOXXA

Series B in 2014
AYOXXA Biosystems GmbH is a life science tools company based in Cologne, Germany, with additional offices in Singapore and Boston, Massachusetts. Founded in 2010, AYOXXA specializes in developing a proprietary technology platform for multiplexed protein analysis. This platform, which utilizes In-situ Encoded Bead-based Arrays, enables users to simultaneously measure multiple protein markers associated with various health conditions, including cancer, allergies, cardiovascular diseases, and infectious diseases. AYOXXA's innovative biochips merge biological analysis with information technology, expanding the potential applications in biomedical research. The company also offers biomarker kits to facilitate the identification and quantification of proteins and other biomolecular analytes.

CryoTherapeutics

Series A in 2014
CryoTherapeutics GmbH, founded in 2009 and based in Cologne, Germany, specializes in developing a proprietary cryotherapy system aimed at treating coronary artery disease, which is a leading cause of heart attacks. The company focuses on demonstrating clinical benefits and advancing early-stage commercialization of its innovative catheter system that employs cryoenergy to address issues related to diseased coronary arteries. By proving the safety and efficacy of cryoenergy in the cardiovascular context, CryoTherapeutics aims to provide heart surgeons with an effective tool to prevent heart attacks and enhance patient outcomes.

evocatal

Series B in 2013
evocatal develops and produces enzymes and fine chemicals for the chemical and pharmaceutical industries. We offer a catalog of enzymes (evozymes) as well as and tailor-made biocatalysts for specific industrial applications. Our biocatalysts are applied in various consumer goods industries, including the production and refinement of textiles, adhesives, detergents, nutrition and cosmetics. Our customers regard evocatal as a premium provider of high quality chiral building blocks (evochemicals): from a few grams to several tons. At evocatal we have also continued to focus on providing efficient biocatalytic processes as a service (evoservices). Do you need a biocatalyst for a very specific application? Contact us!

Saperatec

Seed Round in 2013
Saperatec, founded in December 2010, is based in Bielefeld, where it operates comprehensive production facilities focused on the separation of bonded and coated materials. The company specializes in recycling technology that enables the processing of multi-layer materials into secondary raw materials. Utilizing both physical and chemical principles, Saperatec's innovative technology enhances the conversion of waste into recyclable materials, providing valuable recycling alternatives for various products. Additionally, the facility includes a laboratory dedicated to exploring and developing new technologies, further advancing the company's capabilities in the recycling sector.

GreenPocket

Series B in 2012
GreenPocket GmbH, founded in 2009 and based in Cologne, Germany, specializes in energy management software designed for utility companies. The company provides solutions for interpreting and visualizing smart metering data, including a household customer portal and energy management software tailored for commercial clients. Their offerings encompass various tools such as a web portal for real-time energy consumption visualization, a business customer portal for cost-saving comparisons, and smart home solutions that optimize the control of household appliances. By leveraging innovative technologies like artificial intelligence and data science, GreenPocket aims to create significant value from smart meter data, thereby supporting energy suppliers and corporate customers in the transition towards a more sustainable energy future. With experience in over 125 projects across 12 countries, GreenPocket is positioned as a trusted partner in the digitalization of the energy industry.

Azeti

Series A in 2011
Azeti GmbH, based in Berlin, Germany, specializes in Internet of Things (IoT) software solutions that enable industrial companies to optimize their data management and infrastructure. Founded in 2006 and operating as a subsidiary of Aurubis AG since July 2020, Azeti provides a range of M2M solutions, including the SONARPLEX product line, which supports logistics companies in monitoring vehicle conditions, fuel consumption, and driver activities in real-time. The company also offers SonarWise for connecting remote cell sites to network operations, SONARMANAGER as a centralized application for managing appliances, and the azeti Lab app for mobile access. Its Social Sensor Cloud facilitates interaction among sensors and actuators, while the platform supports applications in telecommunications, data centers, and transportation. By delivering tailored solutions and fostering long-term customer relationships, Azeti has successfully implemented numerous projects across diverse industries, focusing on condition monitoring, predictive maintenance, and performance analysis.

CEVEC Pharmaceuticals

Venture Round in 2011
CEVEC Pharmaceuticals GmbH specializes in the manufacture of biopharmaceutical molecules featuring human glycosylation patterns. The company develops the CAP-GO platform, which includes optimized expression vectors and a cell line generation process that is free from serum and animal components. This platform enables the efficient production of complex, glycosylated proteins and therapeutic proteins, including monoclonal antibodies. CEVEC also offers the CAP-GT platform for the industrial-scale production of gene therapy vectors, such as Lentiviral, Adenoviral, and AAV types. Additionally, the company provides contract manufacturing services. Founded in 2001 and based in Cologne, Germany, CEVEC has established a strategic collaboration with BioLamina AB to enhance its capabilities in biopharmaceutical production.

NonWoTecc Medical

Series B in 2011
NonWoTecc GmbH was founded with the financial support of High-Tech Gründerfond (HTGF) and Rheinland Venture Capital Fond (RVC) in February of 2007. The goal was to develop a newly designed vascular prosthesis with improved biocompatible and bio-stable properties. NonWoTecc GmbH was one of only seven companies which received a commitment for financial support from HTGF in 2006.

Vimecon

Venture Round in 2011
Vimecon GmbH, founded in 2005 and headquartered in Herzogenrath, Germany, specializes in the development and production of laser catheters specifically designed for the treatment of heart diseases, with a primary focus on atrial fibrillation. The company also manufactures a range of products for the medical technology and biotechnology sectors, including microscopically small catheters and micro materials handling techniques that facilitate precise measurement and dosage. Additionally, Vimecon provides advisory services to various clients in both academic and industrial research and development. Its innovations aim to enhance healthcare outcomes and support advancements in the treatment of cardiovascular diseases and cardiac arrhythmias.

simfy

Venture Round in 2011
simfy GmbH operates as an online music platform. The company allows to share and store music online, as well as to listen instantly to specific tracks or albums via true on demand streaming. simfy GmbH was founded in 2006 and is based in Cologne, Germany.

Fashionette

Venture Round in 2011
Fashionette AG is an online retailer specializing in fashion accessories across Europe, offering a wide range of products including handbags, shoes, sunglasses, watches, and jewelry. Founded in 2008 and headquartered in Düsseldorf, Germany, the company focuses on providing customers with a curated selection of luxury items. With a commitment to quality and style, Fashionette has established itself as a prominent player in the online fashion market, catering to a diverse clientele seeking fashionable accessories.

Protagen

Venture Round in 2010
Protagen is a precision medicine specialist that support drug development, facilitate treatment strategies and improve patient management. Protagen is at the forefront of immuno-profiling and the discovery of novel autoantibody signatures for autoimmune disease and immuno-oncology. Protagen’s SeroTag® technology identifies biomarkers that address a number of challenges currently hindering the successful development and broader application of both cancer immunotherapies and novel treatments for autoimmune diseases. The company is a leader in patient stratification for autoimmune disease, having developed disease-specific NavigAID stratification panels that profile individual patient’s autoimmune condition and immune status. This precision medicine approach allows for the development and implementation of more targeted therapies for diseases such as systemic lupus erythematosus (SLE), systemic sclerosis (SSc), rheumatoid arthritis (RA), Sjögren’s syndrome (SjS) and others.

simfy

Venture Round in 2010
simfy GmbH operates as an online music platform. The company allows to share and store music online, as well as to listen instantly to specific tracks or albums via true on demand streaming. simfy GmbH was founded in 2006 and is based in Cologne, Germany.
Direvo Industrial Biotechnology GmbH, founded in 2008 and based in Cologne, Germany, specializes in developing and marketing biology-based products and processes for non-pharmaceutical industries. The company focuses on providing bio-based solutions in clean energy, clean chemistry, and biomass conversion markets by leveraging its expertise in enzymes and microbes. Its BluZy platform features technologies tailored for the grain ethanol industry, enhancing both the nutritional value of by-products and the efficiency of ethanol production processes. Additionally, the BluServ platform offers automated high-throughput screening for protein and strain engineering, while the BluCon technology facilitates the conversion of non-food feedstocks into carbohydrates for fuel and chemical production. Direvo collaborates with major industry players and is privately owned, with investments from various equity partners and private investors.

CEVEC Pharmaceuticals

Series B in 2010
CEVEC Pharmaceuticals GmbH specializes in the manufacture of biopharmaceutical molecules featuring human glycosylation patterns. The company develops the CAP-GO platform, which includes optimized expression vectors and a cell line generation process that is free from serum and animal components. This platform enables the efficient production of complex, glycosylated proteins and therapeutic proteins, including monoclonal antibodies. CEVEC also offers the CAP-GT platform for the industrial-scale production of gene therapy vectors, such as Lentiviral, Adenoviral, and AAV types. Additionally, the company provides contract manufacturing services. Founded in 2001 and based in Cologne, Germany, CEVEC has established a strategic collaboration with BioLamina AB to enhance its capabilities in biopharmaceutical production.

DIREVO Industrial Biotechnology

Venture Round in 2010
Direvo Industrial Biotechnology GmbH, founded in 2008 and based in Cologne, Germany, specializes in developing and marketing biology-based products and processes for non-pharmaceutical industries. The company focuses on providing bio-based solutions in clean energy, clean chemistry, and biomass conversion markets by leveraging its expertise in enzymes and microbes. Its BluZy platform features technologies tailored for the grain ethanol industry, enhancing both the nutritional value of by-products and the efficiency of ethanol production processes. Additionally, the BluServ platform offers automated high-throughput screening for protein and strain engineering, while the BluCon technology facilitates the conversion of non-food feedstocks into carbohydrates for fuel and chemical production. Direvo collaborates with major industry players and is privately owned, with investments from various equity partners and private investors.

audimark GmbH

Venture Round in 2010
The audimark GmbH positions itself as a market-leading marketer of web radios.

CEVEC Pharmaceuticals

Series A in 2009
CEVEC Pharmaceuticals GmbH specializes in the manufacture of biopharmaceutical molecules featuring human glycosylation patterns. The company develops the CAP-GO platform, which includes optimized expression vectors and a cell line generation process that is free from serum and animal components. This platform enables the efficient production of complex, glycosylated proteins and therapeutic proteins, including monoclonal antibodies. CEVEC also offers the CAP-GT platform for the industrial-scale production of gene therapy vectors, such as Lentiviral, Adenoviral, and AAV types. Additionally, the company provides contract manufacturing services. Founded in 2001 and based in Cologne, Germany, CEVEC has established a strategic collaboration with BioLamina AB to enhance its capabilities in biopharmaceutical production.
Direvo Industrial Biotechnology GmbH, founded in 2008 and based in Cologne, Germany, specializes in developing and marketing biology-based products and processes for non-pharmaceutical industries. The company focuses on providing bio-based solutions in clean energy, clean chemistry, and biomass conversion markets by leveraging its expertise in enzymes and microbes. Its BluZy platform features technologies tailored for the grain ethanol industry, enhancing both the nutritional value of by-products and the efficiency of ethanol production processes. Additionally, the BluServ platform offers automated high-throughput screening for protein and strain engineering, while the BluCon technology facilitates the conversion of non-food feedstocks into carbohydrates for fuel and chemical production. Direvo collaborates with major industry players and is privately owned, with investments from various equity partners and private investors.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.